Not really. And that is my first point. While there is no explicit mention of FTO in phase 1a/b or phase 2 trials, the FTO data will be collected. I am guessing they are not saying they will prove FTO effects of Bisantrene but still collect the data package for BP? Why not make it clearer in the strategy and communicate it to SHs?
Not really. And that is my first point. While there is no...
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.87 |
Change
-0.155(7.67%) |
Mkt cap ! $317.5M | |||
| Open | High | Low | Value | Volume |
| $2.03 | $2.08 | $1.86 | $706.9K | 357.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2637 | $1.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.87 | 577 | 1 |
View Market Depth
| Last trade - 16.10pm 20/06/2024 (20 minute delay) ? |
| RAC (ASX) Chart |